Back to News
Market Impact: 0.1
One in Three U.S. Adults Delay, Stretch, or Don’t Fill Prescriptions When Costs Are Unclear, According to New Model N Research
Source: GlobeNewswire
Healthcare & BiotechConsumer Demand & Retail
A survey found significant uncertainty around prescription drug prices and limited public awareness of the stakeholders that determine insurance coverage and medication access. The findings highlight ongoing opacity in healthcare pricing and potential barriers for patients, but provide no company-specific financial data or market-moving policy development.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- Meta announces new lightweight virtual reality glasses to one-up Apple’s Vision Pro
- US aviation sanctions disrupt Iran flights, push travellers overland
- Here's what happens to the economy when Treasury yields soar like they are now
- Oil industry warns a diesel export ban will raise fuel prices as Trump weighs restrictions
- Australia says OpenAI agent hacked Medicare portal
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Introducing AllMind: A New Data & AI Workspace for Institutional Investors
- AI Tools for Private Equity Due Diligence: A Buyer Workflow